CLOROX CO /DE/(CLX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #683 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CLX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for CLOROX CO /DE/ (CLX), a Materials sector company. 13F Pro's AI-powered ranking engine scores CLX at 63.5/100 on a 32-signal composite quality model, placing it at rank #683 of 2,879 stocks — the top 25% of the AI-ranked universe. CLX scores in the top quartile across earnings quality (93.6), balance sheet strength (88.4), revenue scale (81.8). Areas of concern include revenue growth (19.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q3 2026), CLOROX CO /DE/ reports quarterly revenue of $1.7B, net income of $187.0M, an operating margin of 15.3%. Top institutional holders of CLX by reported 13-F value include BlackRock,, STATE STREET, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CLX trades on the NYSE exchange and files with the SEC under CIK 21076. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CLOROX CO /DE/ directly from SEC EDGAR. CLOROX CO /DE/'s 13F Pro composite quality score has ranged between 8 and 75 since 2021, currently 63.5 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q3 2026
$1.7B
Net Income
Q3 2026
$187.0M
Free Cash Flow
Q3 2026
$-165.0M
Operating Margin
Q3 2026
15.3%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-4.0% YoYNet Income
+87.9% YoYEPS (Diluted)
+87.5% YoYTotal Assets
-3.3% YoYTotal Debt
+0.2% YoYOp. Cash Flow
-40.0% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $7.09B -4.0% | $7.39B +4.0% | $7.11B -3.2% | $7.34B +9.2% | $6.72B +8.2% | $6.21B |
| Net Income | $280.0M +87.9% | $149.0M -67.7% | $462.0M -34.9% | $710.0M -24.4% | $939.0M +14.5% | $820.0M |
| EPS (Diluted) | $2.25 +87.5% | $1.20 -67.8% | $3.73 -33.2% | $5.58 -24.2% | $7.36 +16.5% | $6.32 |
| Total Assets | $5.75B -3.3% | $5.95B -3.5% | $6.16B -2.8% | $6.33B +1.9% | $6.21B +21.4% | $5.12B |
| Total Debt | $2.48B +0.2% | $2.48B +0.1% | $2.47B -19.8% | $3.08B +10.9% | $2.78B +3.6% | $2.68B |
| Operating Cash Flow | $695.0M -40.0% | $1.16B +47.3% | $786.0M -38.4% | $1.28B -17.5% | $1.55B +55.8% | $992.0M |
AI Insight: CLX Financial Trends
Revenue remains range-bound while operating cash flow has turned negative in Q1 2026, signaling potential liquidity pressure despite stable debt levels.
• Revenue contracted 4.6% year-over-year in Q1 2026 to $1,670M versus $1,748M estimated Q1 2025 comparable.
• Operating cash flow swung to negative $122M in Q1 2026, the first quarterly decline into negative territory in the dataset.
• Total debt increased marginally from $2,481M in Q2 2024 to $2,487M in Q1 2026, rising 0.2% over nine quarters.
⚠ Negative operating cash flow in Q1 2026 breaks recent pattern of positive conversion; monitor sustainability and working capital swings.
⚠ Equity has deteriorated sharply from $328M in Q2 2024 to negative $67M in Q1 2026; balance sheet erosion accelerating.
AI Insight: CLX Ratio Trends
Clorox margins recovered to mid-teens in Q1 2026 after Q3 2025 collapse, but ROIC volatility signals operational instability.
• OpMargin rebounded to 15.3% in Q1 2026 from 7.5% in Q3 2025; NPM similarly recovered to 11.2% from 5.6%.
• ROIC expanded to 42.3% in Q1 2026, highest since Q2 2025's 58.5%, reversing Q3 2025 collapse to 17.4%.
• D/E ratio flat at ~7.7x in Q2 2025–Q2 2026 period, indicating stable leverage despite earnings volatility.
⚠ Q3 2025 saw dramatic margin/ROIC compression (OpMargin 7.5%, ROIC 17.4%)—root cause and recurrence risk unclear.
⚠ Annualized metrics show extreme quarterly swings; Q2 2025 ROIC of 58.5% followed by 17.4% suggests seasonality or one-offs masking true run-rate.
Get alerted when CLX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CLOROX CO /DE/ including:
Top Institutional Holders of CLX
BlackRock, Inc.
$1.1B10,171,871 shSTATE STREET CORP
$855.4M8,254,575 shVANGUARD CAPITAL MANAGEMENT LLC
$813.5M7,850,437 shVANGUARD PORTFOLIO MANAGEMENT LLC
$599.5M5,784,592 shInvesco Ltd.
$503.6M4,859,240 shGEODE CAPITAL MANAGEMENT, LLC
$333.3M3,228,680 shMORGAN STANLEY
$281.5M2,716,044 shPoint72 Asset Management, L.P.
$165.0M1,592,288 shNORTHERN TRUST CORP
$165.0M1,591,829 shProShare Advisors LLC
$157.1M1,515,910 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $1.1B | 10,171,871 |
| STATE STREET CORP | $855.4M | 8,254,575 |
| VANGUARD CAPITAL MANAGEMENT LLC | $813.5M | 7,850,437 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $599.5M | 5,784,592 |
| Invesco Ltd. | $503.6M | 4,859,240 |
| GEODE CAPITAL MANAGEMENT, LLC | $333.3M | 3,228,680 |
| MORGAN STANLEY | $281.5M | 2,716,044 |
| Point72 Asset Management, L.P. | $165.0M | 1,592,288 |
| NORTHERN TRUST CORP | $165.0M | 1,591,829 |
| ProShare Advisors LLC | $157.1M | 1,515,910 |
More Materials Companies
View all Materials →Put CLX on your watchlist
Track score changes the day CLOROX CO /DE/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CLX a good stock to buy?
13F Pro's AI-powered analysis of CLOROX CO /DE/ (CLX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CLX are available on the CLX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CLX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CLX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CLOROX CO /DE/'s investment landscape.